Page 81 - Schwartz Principios de Cirugía, Capítulo 33 Páncreas
P. 81

1420   262. Gloor B, Friess H, Uhl W, et al. A modified technique of the   281. Deol ZK, Frezza E, DeJong S, Pickleman J. Solitary hepatic gas-
             Beger and Frey procedure in patients with chronic pancreatitis.   trinoma treated with laparoscopic radiofrequency ablation. JSLS.
             Dig Surg. 2001;18:21-25.                              2003;7:285-289.
          263. Koninger J, Seiler CM, Sauerland S, et al. Duodenum-preserving   282. Case CC, Wirfel K, Vassilopoulou-Sellin R. Vasoactive intes-
             pancreatic head resection—a randomized controlled trial com-  tinal polypeptide-secreting tumor (VIPoma) with liver metas-
             paring the original Beger procedure with the Berne modification   tases: dramatic and durable symptomatic benefit from hepatic
             (ISRCTN No. 50638764). Surgery. 2008;143:490-498.     artery embolization, a case report.  Med Oncol. 2002;19:
          264. Izbicki JR, Bloechle C, Broering DC, et al. Extended drainage   181-187.
             versus resection in surgery for chronic pancreatitis: a prospec-  283. Tanaka S, Yamasaki S, Matsushita H, et al. Duodenal somatostati-
             tive randomized trial comparing the longitudinal pancreaticoje-  noma: a case report and review of 31 cases with special reference
             junostomy combined with local pancreatic head excision with   to the relationship between tumor size and metastasis. Pathol Int.
             the pylorus-preserving pancreatoduodenectomy.  Ann Surg.   2000;50:146-152.
             1998;228:771-779.                                  284. Raymond E et al. Updated results of the phase III trial of sunitinib
          265. Strate T, Bachmann K, Busch P, et al. Resection vs. drainage in   (SU) versus placebo (PBO) for treatment of advanced pancreatic
             treatment of chronic pancreatitis: long-term results of a random-  neuroendocrine tumors (NET). ASCO 2010 Gastrointestinal Can-
             ized trial. Gastroenterology. 2008;134:1406-1411.     cers Symposium Abstr 127.
     parTe ii
          266. Klempa I, Spatny M, Menzel J, et al. Pancreatic function and   285.  Kulke M et al. Phase I/II study of everolimus (RAD001) in combi-
             quality of life after resection of the head of the pancreas in   nation with temozolomide (TMZ) in patients with advanced pan-
             chronic  pancreatitis. A  prospective,  randomized  compara-  creatic neuroendocrine tumors (NET) ASCO 2010.
             tive study after duodenum preserving resection of the head of   286. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA:
             the pancreas versus Whipple’s operation.  Chirurg. 1995;66:   A Cancer Journal for Clinicians. 2011; 61: 69-90.
             350-359.                                           287. Seigel R, Naishadham D, Jemal A. Cancer statistics 2012. CA: A
          267. Buchler MW, Friess H, Bittner R, et al. Duodenum-preserving   Cancer Journal for Clinicians. 2012; 62:10-29.
             pancreatic head resection: long-term results. J Gastrointest Surg.   288. http://seer.cancer.gov/statfacts/html/pancreas.html: SEER Stat
             1997;1:13-19.                                         Fact Sheets. [Accessed March 20, 2009.]
          268. Zheng Z, Xiang G, Tan C, et al. Pancreaticoduodenectomy vs.   289. Cui YF, Andersen DK. Diabetes and pancreatic cancer.
             duodenum-preserving pancreatic head resection for the treatment   Endocr Rel Cancer. 2012; 19: F9-F26.
             of chronic pancreatitis. Pancreas. 2012;41:147-152.  290. Gold EB, Goldin SB: Epidemiology of and risk factors for pan-
          269. Strate T, Taherpour Z, Bloechle C, et al. Long term follow-up   creatic cancer. Surg Oncol Clin N Am. 1998;7:67.
             of a randomized trial comparing the Beger and Frey proce-  291. Fisher WE. Diabetes: Risk factor for the development of pan-
     ConsideraCiones espeCífiCas
             dures for patients suffering from chronic pancreatitis. Ann Surg.   creatic cancer or manifestation of the disease? World J Surg.
             2005;241:591.                                         2001;25:503.
          270. Riediger H, Adam U, Fischer E, et al. Long-term outcome after
             resection for chronic pancreatitis in 224 patients. J Gastrointest   292. Jean M, Lowy A, Chiao P, et al: The Molecular Biology of Pan-
             Surg. 2007;11:949-959, discussion 959-960.            creatic Cancer. New York: Springer-Verlag; 2002.
          271. Ramesh H, Jacob G, Lekha V, Venugopal A. Ductal drainage   293. Berger D, Fischer W. Inherited Pancreatic Cancer Syndromes.
             with head coring in chronic pancreatitis with small-duct disease.   New York: Springer-Verlag; 2002.
             J Hepatobiliary Pancreat Surg. 2003;10:366-372.    294. Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer
          272. Shrikhande SV, Kleeff J, Friess H, et al. Management of pain in   genomes reveal aberrations in axon guidance pathway genes.
             small duct chronic pancreatitis. J Gastrointest Surg. 2006;10:227-  Nature. 2012; 491: 399-405.
             233.                                               295. Fisher WE, Muscarella P, Boros LG, et al. Gastrointestinal hor-
          273. Najarian JS, Sutherland DE, Baumgartner D, et al. Total   mones as potential adjuvant treatment of exocrine pancreatic
             or near total pancreatectomy and islet autotransplantation   adenocarcinoma. Int J Pancreatol. 1998;24:169-180.
             for treatment of chronic pancreatitis.  Ann Surg. 1980;192:   296. Biankin AV, Kench JG, Dijkman FP, et al. Molecular patho-
             526-542.                                              genesis of precursor lesions of pancreatic ductal adenocarci-
          274. Sutherland DE, Radosevich DM, Bellin, MA, et al. Total pan-  noma. Pathology. 2003;35:14.
             createctomy and islet autotransplantation for chronic pancre-  297. Wilentz RE, Hruban RH. Pathology of cancer of the pancreas.
             atits. J Am Coll Surg. 2012;214:409-426.              Surg Oncol Clin N Am. 1998;7:43-65.
          275. Robertson  RP,  Lanz  KJ,  Sutherland  DE,  et  al.  Prevention    298. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer sta-
             of  diabetes  for  up  to  13  years  by  autoislet  transplantation   tistics review 1975-2009 (Vintage 2009 populations) National
             after pancreatectomy for chronic pancreatitis.  Diabetes.   Cancer Institute, Betheda. Available at: http://seer.cancer.gov/
             2001;50:47-50.                                        csr/1975_2009_pops09/.
          276. Rastellini C. Donor and recipient selection in pancreatic islet   299. Ritts R, Pitt H. CA19-9 in pancreatic cancer. Surg Oncol Clin N
             transplantation. Curr Opin Organ Transplant. 2002;7:196.  Am. 1998;7:93-101.
          277. Richards ML, Gauger PG, Thompson NW, Kloos RG,    300. Iacobuzio-Donahue CA, Maitra A, Olsen M, et al. Explora-
             Giordano T. Pitfalls in the surgical treatment of insulinoma. Sur-  tion of global gene expression patterns in pancreatic adeno-
             gery. 2002;132:1040-1049, discussion 1049.            carcinoma using cDNA microarrays. Am J Pathol. 2003;162:
          278. Howard TJ, Stabile BE, Zinner MJ, Chang S, Bhagavan BS, Pas-  1151-1162.
             saro E Jr. Anatomic distribution of pancreatic endocrine tumors.   301. Squillaci E, Fanucco E, Scuito F: Vascular involvement in pan-
             Am J Surg. 1990;159:258-264.                          creatic neoplasm: a comparison between spiral CT and DSA. Dig
          279. Service FJ, Natt N, Thompson GB, et al. Noninsulinoma pancrea-  Dis Sci. 2003;48:449-458.
             togenous hypoglycemia: A novel syndrome of hyper-insulinemic   302. Kim HJ, Conlon KC: Laparoscopic Staging. New York: Springer-
             hypoglycemia in adults independent of mutations in Kir6.2 and   Verlag; 2002.
             SUR1 genes. J Clin Endocrinol Metab. 1999; 84: 1582-1589.  303. Shah RJ, Howell DA, Desilets DJ, et al. Multicenter ran-
          280.  Cui YF, Elahi D, Andersen DK. Advances in the etiology and   domized trial of the spiral Z-stent compared with the Wall-
             management of hyperinsulinemic hypoglycemia after Roux-en-  stent for malignant biliary obstruction. Gastrointest Endosc.
             Y gastric bypass. J Gastrointest Surg. 2011;15: 1879-1888.  2003;57:830-836.

                                                   booksmedicos.org
   76   77   78   79   80   81   82   83